Coming Soon

In the wake of the Supreme Court ruling last week that invalidated patents on isolated gene sequences held by Myriad Genetics, a number of companies are jumping in to offer BRCA1 and BRCA2 testing. Pharmacogenomics Reporter notes that Ambry Genetics, GeneDx, Gene by Gene, Pathway Genomics, and the University of Washington have said that they will be launching BRCA gene tests.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.